TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway
{{output}}
Background & aims: Hepatocellular carcinoma (HCC) is an aggressive malignancy with few effective treatment options. H3Q5ser, a serotonin-based histone modification mediated by transglutaminase 2 (TGM2), affects diverse biological... ...
